세계의 줄기세포 어세이 시장 보고서(2025년)

Stem Cell Assay Global Market Report 2025

US $ 4,490 ￦ 6,253,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,039,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,824,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

줄기세포 어세이 시장 규모는 향후 몇 년 동안 비약적인 성장을 보일 것으로 예상되며, 2029년에는 연평균 22.4%의 CAGR로 64억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 주요 동향으로는 3D 세포배양 모델, 하이스루풋 스크리닝, 맞춤형 의료, crispr-cas9 및 유전체 편집, 약물 안전성 및 독성 테스트 등이 있습니다.

만성질환의 유병률 증가는 향후 줄기세포 어세이 시장의 성장을 촉진할 것으로 예상됩니다. 만성질환은 3개월 이상 지속되고 시간이 지남에 따라 악화될 가능성이 있는 질병이나 질환으로 정의됩니다. 줄기세포는 만성질환을 포함한 다양한 질병을 치료할 수 있는 잠재력을 가지고 있습니다. 줄기세포는 암과 같은 만성질환 치료에 도움이 되는 새로운 항체나 특수 세포의 개발을 촉진합니다. 예를 들어, 2022년 영국에 본부를 둔 세계암연구기금 인터내셔널의 데이터에 따르면, 영국의 폐암 환자 수는 50,700명으로 인구 10만 명당 30.1명의 비율에 해당합니다. 같은 해 영국에서는 16,855명의 여성이 폐암으로 사망했으며, 사망률은 10만 명당 17.4명이었습니다. 또한 2024년 3월 영국 정부의 데이터에 따르면 2023년 회계연도까지 영국에서 186만2500명, 즉 인구의 3%가 관상동맥성 심장병(CHD)으로 GP 진단을 받은 것으로 나타났습니다. 결과적으로 만성질환의 유병률 증가는 줄기세포 어세이 시장의 성장을 촉진하고 있습니다.

헬스케어 분야의 성장은 줄기세포 어세이 시장의 성장을 촉진할 것으로 예측됩니다. 헬스케어 부문은 헬스케어 산업 또는 헬스케어 시스템이라고도 하며, 사람들의 건강 유지 및 증진을 목적으로 하는 의료 서비스, 헬스케어 제품, 지원을 제공하는 조직, 기관, 전문가, 자원의 범위를 포괄합니다. 이 분야에서는 신약 개발, 독성 시험, 질병 모델링, 발생 생물학적 연구 등에 줄기세포 어세이이 활용되고 있습니다. 예를 들어, 간질에 초점을 맞춘 영국의 국가 통계 기관인 Office for National Statistics가 2022년에 발표한 데이터에 따르면, 영국의 헬스케어 지출은 약 3,548억 8,000만 달러(2,830억 파운드)에 달해 2021년 지출 대비 명목상 0.7% 증가하였습니다. 0.7% 증가했습니다. 따라서 헬스케어 분야의 성장은 향후 줄기세포 어세이 시장의 성장을 촉진할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 줄기세포 어세이 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업 분석
• 세계의 줄기세포 어세이 시장 : 성장률 분석
• 세계의 줄기세포 어세이 시장 실적 : 규모와 성장, 2019-2024
• 세계의 줄기세포 어세이 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계의 줄기세포 어세이 전체 시장(TAM)

제6장 시장 세분화

• 세계의 줄기세포 어세이 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세포 생존율 및 독성 시험
• 세포 아포토시스 어세이
• 세포 기능 어세이
• 세포 동정 어세이
• 분리 및 정제 어세이
• 세포 분화 어세이
• 기타 유형
• 세계의 줄기세포 어세이 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 기기
• 검출 키트
• 세계의 줄기세포 어세이 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 재생의료와 치료법 개발
• 의약품 발견과 개발
• 임상 조사
• 세계의 줄기세포 어세이 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 정부 연구기관
• 민간 연구기관
• 산업 연구
• 세계의 줄기세포 어세이 시장 : 세포 생존율 및 독성 시험 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• MTT 어세이
• 레자즈린앗세이
• ATP 어세이
• LDH 방출 어세이
• 세계의 줄기세포 어세이 시장 : 세포 아포토시스 어세이 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 카스파제 활성 어세이
• 아넥신 V염색 어세이
• TUNEL 어세이
• 세포사 검출 어세이
• 세계의 줄기세포 어세이 시장 : 세포 기능 어세이 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 증식 어세이
• 이동 및 침입 어세이
• 분화 어세이
• 세계의 줄기세포 어세이 시장 : 세포 식별 어세이 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 유세포 분석 기반 어세이
• 표면 마커 특성 평가
• 면역세포화학 어세이
• 세계의 줄기세포 어세이 시장 : 분리 및 정제 어세이 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 자기 활성화 세포 선별(MACS)
• 형광 활성화 세포 선별법(FACS)
• 밀도 구배 원심분리
• 세계의 줄기세포 어세이 시장 : 세포 분화 어세이 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 계통 특이적 분화 어세이
• 분화중 유전자 발현 분석
• 세계의 줄기세포 어세이 시장 : 기타 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 3D 배양 어세이
• HCS(High Content Screening) 어세이
• 바이오마커 탐색 어세이

제7장 지역별·국가별 분석

• 세계의 줄기세포 어세이 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 줄기세포 어세이 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 줄기세포 어세이 시장 : 경쟁 구도
• 줄기세포 어세이 시장 : 기업 개요
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• PerkinElmer Inc.
• Agilent Technologies Inc.
• Promega Corporation
• Cell Biolabs Inc.
• Miltenyi Biotec GmbH
• STEMCELL Technologies Inc.
• Bio-Techne Corporation
• Charles River Laboratories International Inc.
• Hemogenix Inc.
• Lonza Group AG
• Takara Bio Inc.
• Creative Bioarray
• AAT Bioquest Inc.
• BPS Bioscience Inc.
• Enzo Life Sciences Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 줄기세포 어세이 시장 2029 : 새로운 기회를 제공하는 국가
• 줄기세포 어세이 시장 2029 : 새로운 기회를 제공하는 부문
• 줄기세포 어세이 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Stem cells are cells possessing the unique ability to self-renew and differentiate into specialized cell types, serving as the foundational elements for all living organisms. Stem cell assays are specifically designed to explore the growth of human stem cells and examine their biological activities within a controlled environment.

The primary categories within the stem cell assays market include cell viability and toxicity assays, cell apoptosis assays, cell function assays, cell identification assays, isolation and purification assays, and cell differentiation assays, among others. Cell viability and toxicity assays are employed to evaluate the physical and physiological health of cells under various conditions, such as exposure to external stimuli, chemical agents, medicinal treatments, or other factors, aiding in the determination of optimal conditions for cell culture growth. Products associated with these assays include instruments and detection kits utilized in diverse applications like regenerative medicine, therapy development, drug discovery, and clinical research. End users span government research institutes, private research institutes, and industry research.

The stem cell assay market research report is one of a series of new reports from The Business Research Company that provides stem cell assay market statistics, including stem cell assay industry global market size, regional shares, competitors with an stem cell assay market share, detailed stem cell assay market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell assay industry. This stem cell assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell assay market size has grown exponentially in recent years. It will grow from $2.36 billion in 2024 to $2.85 billion in 2025 at a compound annual growth rate (CAGR) of 20.8%. The growth in the historic period can be attributed to biotechnology advancements, drug discovery and development, regenerative medicine research, disease modeling, public and private investment.

The stem cell assay market size is expected to see exponential growth in the next few years. It will grow to $6.41 billion in 2029 at a compound annual growth rate (CAGR) of 22.4%. The growth in the forecast period can be attributed to personalized medicine and cellTherapy, organoid and tissue engineering, ai and machine learning, emerging technologies, regulatory and ethical considerations.Major trends in the forecast period include 3D cell culture models, high-throughput screening, personalized medicine, crispr-cas9 and genome editing, drug safety and toxicity testing.

The rising prevalence of chronic diseases is anticipated to drive the growth of the stem cell assay market in the future. Chronic diseases are defined as ailments or illnesses that persist for three months or longer and may worsen over time. Stem cells possess the potential to treat various diseases, including chronic conditions. They facilitate the development of new antibodies and specialized cells that aid in curing chronic diseases such as cancer. For example, in 2022, data from The World Cancer Research Fund International, a UK-based organization, indicated that there were 50,700 lung cancer cases in the United Kingdom, corresponding to a rate of 30.1 per 100,000 people. That year, 16,855 women died from lung cancer in the UK, resulting in a mortality rate of 17.4 per 100,000. Furthermore, in March 2024, data from The Government of the United Kingdom revealed that in the financial year ending 2023, slightly over 1,862,500 individuals in England, or 3% of the population, received a GP diagnosis of coronary heart disease (CHD). Consequently, the increasing prevalence of chronic diseases is propelling the growth of the stem cell assay market.

The growing healthcare sector is projected to drive the expansion of the stem cell assay market. The healthcare sector, also referred to as the healthcare industry or healthcare system, encompasses a range of organizations, institutions, professionals, and resources committed to delivering medical services, healthcare products, and support aimed at maintaining or enhancing people's health. Within this sector, stem cell assays are utilized for drug discovery and development, toxicity testing, disease modeling, and exploring developmental biology. For example, in 2022, data from the Office for National Statistics, a UK-based national statistics organization focused on epilepsy, indicated that healthcare expenditure in the UK reached approximately $354.88 billion (£283 billion), reflecting a nominal increase of 0.7% compared to 2021 spending. Therefore, the growing healthcare sector is expected to propel the growth of the stem cell assay market in the future.

A key trend gaining traction in the stem cell assay market is product innovation. Major companies in this market are introducing new products to maintain their competitive positions. For example, in May 2022, Beckman Coulter Life Sciences, a US-based healthcare company, introduced the AQUOS STEM System designed to aid in the development of hematopoietic stem cells. This system reduces hands-on time by 95%, minimizes error-prone processes by 87.5%, and shortens turnaround times, running on the AQUIOS CL Flow Cytometer that combines sample preparation and analysis in a compact platform.

Innovative technologies such as the LIVE Cell Death Assay (LCDA) are being developed by major companies in the stem cell assay market to meet the growing demand. LCDA, an automated solution for profiling cell health, death, apoptosis, and necrosis, offers 13 viability and death-related metrics. For instance, in September 2022, Nanolive SA, a Switzerland-based biotechnology company, launched LCDA, which finds applications in drug discovery, enabling the analysis of cell conditions related to health, stress, cell death, and recovery. This method employs machine learning to automatically measure and track cell well-being and the progression of cell death while distinguishing between apoptosis and necrosis.

In July 2022, Fujifilm Cellular Dynamics Inc., a US-based manufacturer of human-induced pluripotent stem cell technologies, entered into a partnership with PhenoVista Biosciences. This collaboration aims to provide drug discovery researchers with services for high content screening imaging using iPSC-derived differentiated cells, contributing to the drug discovery process. PhenoVista Biosciences, a US-based company, specializes in offering imaging-based phenotypic assay services for drug discovery using induced pluripotent stem cells (iPSCs) in screening.

Major companies operating in the stem cell assay market include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Laboratories Inc., PerkinElmer Inc., Agilent Technologies Inc., Promega Corporation, Cell Biolabs Inc., Miltenyi Biotec GmbH, STEMCELL Technologies Inc., Bio-Techne Corporation, Charles River Laboratories International Inc., Hemogenix Inc., Lonza Group AG, Takara Bio Inc., Creative Bioarray, AAT Bioquest Inc., BPS Bioscience Inc., Enzo Life Sciences Inc., PromoCell GmbH, Biotium Inc., Geno Technology Inc., Abcam plc, ReachBio Research Labs. Inc., Sartorius AG, Eppendorf AG, Corning Incorporated, MEDIPOST Co. Ltd., Anterogen Co. Ltd., Corestemchemon Inc., Pharmicell Inc., NuVasive Inc., RTI Surgical Holdings Inc., AlloSource LifeSource Services Inc., JCR Pharmaceuticals Co. Ltd.

North America was the largest region in the stem cell assay market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the global stem cell assay industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the stem cell assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The stem cell assay market consists of sales of tetrazolium reduction assays, resazurin cell viability assays, calcein-AM cell viability assays, proliferation assays, differentiation assays, function assays, caspase assays and annexin v and cell permeability assays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Cell Viability And Toxicity Assays; Cell Apoptosis Assays; Cell Function Assays; Cell Identification Assays; Isolation And Purification Assays; Cell Differentiation Assay; Other Types
• 2) By Product: Instruments; Detection kit
• 3) By Application: Regenerative Medicine And Therapy Development; Drug Discovery And Development; Clinical Research
• 4) By End User: Government Research Institutes; Private Research Institutes; Industry Research
• Subsegments:
• 1) By Cell Viability and Toxicity Assays: MTT Assay; Resazurin Assay; ATP Assay; LDH Release Assay
• 2) By Cell Apoptosis Assays: Caspase Activity Assays; Annexin V Staining Assays; TUNEL Assay; Cell Death Detection Assays
• 3) By Cell Function Assays: Proliferation Assays; Migration and Invasion Assays; Differentiation Assays
• 4) By Cell Identification Assays: Flow Cytometry-Based Assays; Surface Marker Characterization; Immunocytochemistry Assays
• 5) By Isolation and Purification Assays: Magnetic-Activated Cell Sorting (MACS); Fluorescence-Activated Cell Sorting (FACS); Density Gradient Centrifugation
• 6) By Cell Differentiation Assay: Lineage-Specific Differentiation Assays; Gene Expression Analysis During Differentiation
• 7) By Other Types: 3D Culture Assays; High-Content Screening Assays; Biomarker Discovery Assays
• Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; Becton Dickinson and Company; Bio-Rad Laboratories Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stem Cell Assay Market Characteristics

3. Stem Cell Assay Market Trends And Strategies

4. Stem Cell Assay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Stem Cell Assay Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stem Cell Assay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stem Cell Assay Market Growth Rate Analysis
• 5.4. Global Stem Cell Assay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stem Cell Assay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stem Cell Assay Total Addressable Market (TAM)

6. Stem Cell Assay Market Segmentation

• 6.1. Global Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cell Viability And Toxicity Assays
• Cell Apoptosis Assays
• Cell Function Assays
• Cell Identification Assays
• Isolation And Purification Assays
• Cell Differentiation Assay
• Other Types
• 6.2. Global Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Detection Kit
• 6.3. Global Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Regenerative Medicine And Therapy Development
• Drug Discovery And Development
• Clinical Research
• 6.4. Global Stem Cell Assay Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Government Research Institutes
• Private Research Institutes
• Industry Research
• 6.5. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Viability and Toxicity Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• MTT Assay
• Resazurin Assay
• ATP Assay
• LDH Release Assay
• 6.6. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Apoptosis Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Caspase Activity Assays
• Annexin V Staining Assays
• TUNEL Assay
• Cell Death Detection Assays
• 6.7. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Function Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Proliferation Assays
• Migration and Invasion Assays
• Differentiation Assays
• 6.8. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Identification Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Flow Cytometry-Based Assays
• Surface Marker Characterization
• Immunocytochemistry Assays
• 6.9. Global Stem Cell Assay Market, Sub-Segmentation Of Isolation and Purification Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic-Activated Cell Sorting (MACS)
• Fluorescence-Activated Cell Sorting (FACS)
• Density Gradient Centrifugation
• 6.10. Global Stem Cell Assay Market, Sub-Segmentation Of Cell Differentiation Assay, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lineage-Specific Differentiation Assays
• Gene Expression Analysis During Differentiation
• 6.11. Global Stem Cell Assay Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 3D Culture Assays
• High-Content Screening Assays
• Biomarker Discovery Assays

7. Stem Cell Assay Market Regional And Country Analysis

• 7.1. Global Stem Cell Assay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stem Cell Assay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stem Cell Assay Market

• 8.1. Asia-Pacific Stem Cell Assay Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stem Cell Assay Market

• 9.1. China Stem Cell Assay Market Overview
• 9.2. China Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stem Cell Assay Market

• 10.1. India Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stem Cell Assay Market

• 11.1. Japan Stem Cell Assay Market Overview
• 11.2. Japan Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stem Cell Assay Market

• 12.1. Australia Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stem Cell Assay Market

• 13.1. Indonesia Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stem Cell Assay Market

• 14.1. South Korea Stem Cell Assay Market Overview
• 14.2. South Korea Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stem Cell Assay Market

• 15.1. Western Europe Stem Cell Assay Market Overview
• 15.2. Western Europe Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stem Cell Assay Market

• 16.1. UK Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stem Cell Assay Market

• 17.1. Germany Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stem Cell Assay Market

• 18.1. France Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stem Cell Assay Market

• 19.1. Italy Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stem Cell Assay Market

• 20.1. Spain Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stem Cell Assay Market

• 21.1. Eastern Europe Stem Cell Assay Market Overview
• 21.2. Eastern Europe Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stem Cell Assay Market

• 22.1. Russia Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stem Cell Assay Market

• 23.1. North America Stem Cell Assay Market Overview
• 23.2. North America Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stem Cell Assay Market

• 24.1. USA Stem Cell Assay Market Overview
• 24.2. USA Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stem Cell Assay Market

• 25.1. Canada Stem Cell Assay Market Overview
• 25.2. Canada Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stem Cell Assay Market

• 26.1. South America Stem Cell Assay Market Overview
• 26.2. South America Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stem Cell Assay Market

• 27.1. Brazil Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stem Cell Assay Market

• 28.1. Middle East Stem Cell Assay Market Overview
• 28.2. Middle East Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stem Cell Assay Market

• 29.1. Africa Stem Cell Assay Market Overview
• 29.2. Africa Stem Cell Assay Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stem Cell Assay Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stem Cell Assay Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stem Cell Assay Market Competitive Landscape And Company Profiles

• 30.1. Stem Cell Assay Market Competitive Landscape
• 30.2. Stem Cell Assay Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Stem Cell Assay Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc.
• 31.2. Agilent Technologies Inc.
• 31.3. Promega Corporation
• 31.4. Cell Biolabs Inc.
• 31.5. Miltenyi Biotec GmbH
• 31.6. STEMCELL Technologies Inc.
• 31.7. Bio-Techne Corporation
• 31.8. Charles River Laboratories International Inc.
• 31.9. Hemogenix Inc.
• 31.10. Lonza Group AG
• 31.11. Takara Bio Inc.
• 31.12. Creative Bioarray
• 31.13. AAT Bioquest Inc.
• 31.14. BPS Bioscience Inc.
• 31.15. Enzo Life Sciences Inc.

32. Global Stem Cell Assay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Assay Market

34. Recent Developments In The Stem Cell Assay Market

35. Stem Cell Assay Market High Potential Countries, Segments and Strategies

• 35.1 Stem Cell Assay Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stem Cell Assay Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stem Cell Assay Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료